Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    McMillan, R.    Related Articles in PubMed    PubMed Citation    PubMed

PERSPECTIVE

Therapy for Adults with Refractory Chronic Immune Thrombocytopenic Purpura

Robert McMillan, MD

15 February 1997 | Volume 126 Issue 4 | Pages 307-314

Adult chronic immune thrombocytopenic purpura (ITP) is a common hematologic disorder; about 14 000 to 16 000 new cases occur each year in the United States.Initial treatment with corticosteroids and splenectomy results in normal or "safe" platelet counts in more than 70% of patients. Treatment of patients refractory to these two treatments is difficult. This paper describes a structured approach to therapy that is based on a literature review and personal experience, including experience with treatment of chronic ITP in special situations (such as emergent bleeding, pregnancy, and central nervous system bleeding). Treatment of most patients with chronic ITP is fairly straightforward, but management of patients refractory to corticosteroids and splenectomy can be difficult. Large, randomized studies are clearly needed to better evaluate the many types of treatment that are recommended for refractory patients.

Author and Article Information

From the Scripps Clinic and Research Foundation. For the current author address, see end of text.
Grant Support: In part by grants RR00833 and HL37945 from the U.S. Public Health Service.
Requests for Reprints: Robert McMillan, MD, Scripps Clinic and Research Foundation, 10666 North Torrey Pines Road, La Jolla, CA 92037.

This article has been cited by other articles:

				M. Collin, O. Shannon, and L. Bjorck From the Cover: IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions PNAS, March 18, 2008; 105(11): 4265 - 4270. [Abstract] [Full Text] [PDF]

				M. Ruggeri, S. Fortuna, and F. Rodeghiero Heterogeneity of terminology and clinical definitions in adult idiopathic thrombocytopenic purpura: a critical appraisal from a systematic review of the literature Haematologica, January 1, 2008; 93(1): 98 - 103. [Abstract] [Full Text] [PDF]

				E. Elli, M. Parma, P. Perseghin, M. Dassi, E. Terruzzi, D. Belotti, P. Pioltelli, and E.M. Pogliani Successful treatment with T depleted autologous peripheral blood stem cell transplantation of refractory chronic autoimmune thrombocytopenic purpura Haematologica, January 1, 2007; 92(1): e7 - e8. [Abstract] [Full Text] [PDF]

				D. B. Cines and J. B. Bussel How I treat idiopathic thrombocytopenic purpura (ITP) Blood, October 1, 2005; 106(7): 2244 - 2251. [Full Text] [PDF]

				M. Kuwana, S. Nomura, K. Fujimura, T. Nagasawa, Y. Muto, Y. Kurata, S. Tanaka, and Y. Ikeda Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura Blood, February 15, 2004; 103(4): 1229 - 1236. [Abstract] [Full Text] [PDF]

				T. Duperier, F. Brody, J. Felsher, R. M. Walsh, M. Rosen, and J. Ponsky Predictive Factors for Successful Laparoscopic Splenectomy in Patients With Immune Thrombocytopenic Purpura Arch Surg, January 1, 2004; 139(1): 61 - 66. [Abstract] [Full Text] [PDF]

				D. B. Cines, J. B. Bussel, R. B. McMillan, and J. L. Zehnder Congenital and Acquired Thrombocytopenia Hematology, January 1, 2004; 2004(1): 390 - 406. [Abstract] [Full Text] [PDF]

				Y. Cheng, R. S.M. Wong, Y. O.Y. Soo, C. H. Chui, F. Y. Lau, N. P.H. Chan, W. S. Wong, and G. Cheng Initial Treatment of Immune Thrombocytopenic Purpura with High-Dose Dexamethasone N. Engl. J. Med., August 28, 2003; 349(9): 831 - 836. [Abstract] [Full Text] [PDF]

				T. Wells and M. J Kovacs Autoimmune Thrombocytopenia Due to Chronic Lymphocytic Leukemia Treated with Fludarabine Ann. Pharmacother., May 1, 2003; 37(5): 671 - 674. [Abstract] [Full Text] [PDF]

				R. D. Huhn, P. F. Fogarty, R. Nakamura, E. J. Read, S. F. Leitman, M. E. Rick, J. Kimball, A. Greene, K. Hansmann, A. Gratwohl, et al. High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopenia Blood, January 1, 2003; 101(1): 71 - 77. [Abstract] [Full Text] [PDF]

				T. G. DeLoughery Thrombocytopenia in Critical Care Patients J Intensive Care Med, November 1, 2002; 17(6): 267 - 282. [Abstract] [PDF]

				D. B. Cines and V. S. Blanchette Immune Thrombocytopenic Purpura N. Engl. J. Med., March 28, 2002; 346(13): 995 - 1008. [Full Text] [PDF]

				R. Stasi, A. Pagano, E. Stipa, and S. Amadori Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura Blood, August 15, 2001; 98(4): 952 - 957. [Abstract] [Full Text] [PDF]

				R. J. Hansen and J. P. Balthasar Pharmacokinetics, Pharmacodynamics, and Platelet Binding of an Anti-Glycoprotein IIb/IIIa Monoclonal Antibody (7E3) in the Rat: A Quantitative Rat Model of Immune Thrombocytopenic Purpura J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 165 - 171. [Abstract] [Full Text]

				J. E. A. Portielje, R. G. J. Westendorp, H. C. Kluin-Nelemans, and A. Brand Morbidity and mortality in adults with idiopathic thrombocytopenic purpura Blood, May 1, 2001; 97(9): 2549 - 2554. [Abstract] [Full Text] [PDF]

				K. R. McCrae, J. B. Bussel, P. M. Mannucci, G. Remuzzi, and D. B. Cines Platelets: An Update on Diagnosis and Management of Thrombocytopenic Disorders Hematology, January 1, 2001; 2001(1): 282 - 305. [Abstract] [Full Text] [PDF]

				F. Alves-Rosa, C. Stanganelli, J. Cabrera, N. van Rooijen, M. S. Palermo, and M. A. Isturiz Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model Blood, October 15, 2000; 96(8): 2834 - 2840. [Abstract] [Full Text] [PDF]

				Y. C. Cohen, B. Djulbegovic, O. Shamai-Lubovitz, and B. Mozes The Bleeding Risk and Natural History of Idiopathic Thrombocytopenic Purpura in Patients With Persistent Low Platelet Counts Arch Intern Med, June 12, 2000; 160(11): 1630 - 1638. [Abstract] [Full Text] [PDF]

				A. Kakar and V. Prakash Refractory thrombocytopenia, recurrent abortions and inferior vena cava thrombosis Postgrad. Med. J., December 1, 1999; 75(890): 744 - 747. [Full Text]

				H. Frederiksen and K. Schmidt The Incidence of Idiopathic Thrombocytopenic Purpura in Adults Increases With Age Blood, August 1, 1999; 94(3): 909 - 913. [Abstract] [Full Text] [PDF]